Literature DB >> 12193583

Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice.

Erin L Milliken1, Rebecca K Ameduri, Melissa D Landis, Alireza Behrooz, Fadi W Abdul-Karim, Ruth A Keri.   

Abstract

Many risk factors for breast cancer are associated with hormonally regulated events. Although numerous mouse models of mammary cancer exist, few address the roles of hormones in spontaneous tumor formation. Here we report that transgenic mice that overexpress LH, resulting in ovarian hyperstimulation, undergo precocious mammary gland development. A significant increase in proliferation leads to ovary-dependent mammary gland hyperplasia. Transgenic glands morphologically mimic those of wild-type pregnant mice and expression levels of multiple milk protein genes are comparable with what is observed at d 14 of pregnancy. In addition to sustained hyperplasia, spontaneous mammary tumors were observed with a mean latency of 41 wk, indicating that chronic hormonal stimulation causes mammary cancer. Although hormonally induced, these tumors lack expression of progesterone receptor, suggesting that following initiating events, the tumors may become hormone independent. This mouse model likely holds great potential as a tool for discovery of hormone-mediated mechanisms of breast cancer and identification of future targets for breast cancer prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193583     DOI: 10.1210/en.2002-220228

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer.

Authors:  Kristen Weber Lozada; Ruth A Keri
Journal:  Biol Reprod       Date:  2011-06-02       Impact factor: 4.285

2.  EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer.

Authors:  Erin L Milliken; Xiaoxue Zhang; Chris Flask; Jeffrey L Duerk; Paul N MacDonald; Ruth A Keri
Journal:  Cancer Lett       Date:  2005-08-22       Impact factor: 8.679

3.  Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.

Authors:  M D Landis; D D Seachrist; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

4.  Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.

Authors:  Melissa D Landis; Darcie D Seachrist; Marjorie E Montañez-Wiscovich; David Danielpour; Ruth A Keri
Journal:  Oncogene       Date:  2005-08-04       Impact factor: 9.867

5.  Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.

Authors:  E L Milliken; K L Lozada; E Johnson; M D Landis; D D Seachrist; I Whitten; A L M Sutton; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

6.  Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice.

Authors:  Xiong Wang; Yong-Gang Chen; Li Ma; Zhi-Hui Li; Ju-Yi Li; Xin-Guo Liu; Ji-Li Zou; Jin-Hu Wu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-05-16

Review 7.  Animal models for aberrations of gonadotropin action.

Authors:  Hellevi Peltoketo; Fu-Ping Zhang; Susana B Rulli
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 8.  Genetic Models for the Study of Luteinizing Hormone Receptor Function.

Authors:  Prema Narayan
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-29       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.